Cost-effectiveness Study of a Multidisciplinary Weight Loss Method to Improve the Health Condition of Obese Patients
NCT05833464 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-04-27
Summary
Prospective, observational, multicenter study based on a registry of patients with obesity and associated comorbidities undergoing a standardized multidisciplinary weight loss method with a 2-year follow-up.
Conditions
Sponsors & Collaborators
-
Protein Supplies SL
lead OTHER
Principal Investigators
-
Rosana Cafardo, Ph · Hospital Italiano de Buenos Aires, Argentina
-
Lucio Criado, Ph · Centro Médico Mansilla. Buenos Aires. Argentina
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-31
- Primary Completion
- 2021-07-31
- Completion
- 2021-09-30
Countries
- Argentina
Study Locations
More Related Trials
-
A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity
NCT06717425 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics and Pharmacodynamics Study to Evaluate BMS-830216 in Obese Subjects
NCT00909766 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of HS-20094 in Chinese Adults with Overweight or Obesity
NCT06839664 ·Status: RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of Low Doses of V24343 in Obese Subjects
NCT00734201 ·Status: COMPLETED ·Phase: PHASE1
-
VLCD by Enteral Route for Weight Loss
NCT01965990 ·Status: COMPLETED
-
Efficacy and Safety of ATL-962 in Obese Diabetics
NCT00156897 ·Status: COMPLETED ·Phase: PHASE2
-
Study Exploring the Supportive Effect of Acarbose in Weight Management
NCT05934110 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
NCT04881760 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Fat Malabsorption by Lipiblock Versus Xenical
NCT01170806 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Obesity
NCT04707313 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese Subjects
NCT00189514 ·Status: COMPLETED ·Phase: PHASE2
-
A Research Study Looking at New Protein-based Tablets in Healthy Male Participants
NCT05129891 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
NCT06845202 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
NCT04839237 ·Status: WITHDRAWN ·Phase: PHASE2
-
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
NCT03479762 ·Status: COMPLETED
-
A 14-Month Study On The Effects Of CP-945,598 For The Prevention Of Weight Regain In Obese Patients
NCT00483171 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects
NCT01597609 ·Status: COMPLETED ·Phase: PHASE1
-
Weight Changes After Incretin-mimetics
NCT06795360 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
NCT03486392 ·Status: COMPLETED ·Phase: PHASE2
-
The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients
NCT04605861 ·Status: COMPLETED ·Phase: PHASE3
-
A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)
NCT00092872 ·Status: COMPLETED ·Phase: PHASE3
-
Obese Patients With or Without Comorbidities (RIO-North America)
NCT00029861 ·Status: COMPLETED ·Phase: PHASE3
-
Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy
NCT06484868 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects
NCT00537420 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.
NCT03856047 ·Status: COMPLETED ·Phase: PHASE2